Bridging: Biotechnology + Clinical Orthopaedics
The Regenerative Orthopaedics Conference San Francisco (ROCSF) is designed to bridge the worlds of biotechnology and clinical orthopedics and accelerate the availability of novel therapeutics in musculoskeletal care. It is the partner conference to the Digital Orthopaedics Conference San Francisco (DOCSF) and focuses on making innovative care available to MSK patients.
Why orthopedics/MSK? We believe that many emerging technologies in the biological sciences can be meaningfully applied within this integrated vertical that extends from acute injury to rheumatologic diseases. ROCSF brings together leaders from academia, biotech, industry, pharma, health systems, government and finance to focus on a narrow use case that nonetheless involves 30% of all primary care visits: musculoskeletal injury and its prevention.
We believe a focused approach is more likely to drive progress and remove barriers than broader, less targeted interventions. At ROCSF, exceptional speakers will elucidate and outline the key opportunities for bridging biotechnology and clinical orthopedics.
To focus the audience on solving the practical challenges faced by innovators working in regenerative orthopedics, ROCSF will select several start-ups to present case studies through the ROCSF Innovation Awards competition which will be run in partnership with incubators and investors such as StartUp Health.
Further, an interactive exhibition hall will showcase the latest technology and developments. And because change does not happen in a vacuum, we have segments on financing biotechnological innovation, understanding the regulatory framework, and how to successfully bring a product to market with our content expert partners.
As ROCSF will be small enough to enable successful networking and collaboration, it will be live streamed and made available to researchers, clinicians and innovators around the world.